NFKB1 and proteostasis deficiencies: Our finding that suppression of neuronal NF-κB activity with IκB-SR alleviated proteinopathies and behavioral phenotypes in three mouse models of ALS or FTLD suggests that the NF-κB pathway in neurons constitutes a promising therapeutic target.